These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 27129712

  • 21. Comparison of the effects of valsartan plus activated vitamin D versus valsartan alone in IgA nephropathy with moderate proteinuria.
    Xiaowei L, Bo W, Li L, Peng Z.
    Int Urol Nephrol; 2020 Jan; 52(1):129-136. PubMed ID: 31768803
    [Abstract] [Full Text] [Related]

  • 22. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of immunosuppressive therapies in the treatment of high-risk IgA nephropathy: A network meta-analysis.
    Liu T, Wang Y, Mao H, Yang L, Zhan Y.
    Medicine (Baltimore); 2021 Feb 26; 100(8):e24541. PubMed ID: 33663060
    [Abstract] [Full Text] [Related]

  • 24. Treatment of IgA nephropathy with renal insufficiency.
    Pozzi C, Sarcina C, Ferrario F.
    J Nephrol; 2016 Aug 26; 29(4):551-8. PubMed ID: 26743078
    [Abstract] [Full Text] [Related]

  • 25. Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study.
    Si FL, Tang C, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H.
    BMC Nephrol; 2023 Jun 15; 24(1):175. PubMed ID: 37322444
    [Abstract] [Full Text] [Related]

  • 26. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul 15; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy of low-dose cyclosporine and steroid in adults with IgA nephropathy
.
    Ihm HS, Lee JY, Hwang HS, Kim YG, Moon JY, Lee SH, Jeong KH, Lee TW, Ihm CG.
    Clin Nephrol; 2019 Sep 15; 92(3):131-140. PubMed ID: 31232271
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun 15; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

  • 29. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
    Rivedal M, Haaskjold YL, Eikrem Ø, Bjørneklett R, Marti HP, Knoop T.
    BMC Nephrol; 2024 Jan 29; 25(1):42. PubMed ID: 38287343
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
    Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ, Lv JC, Zhang H.
    BMC Nephrol; 2019 Aug 05; 20(1):297. PubMed ID: 31382914
    [Abstract] [Full Text] [Related]

  • 31. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):947-955. PubMed ID: 27026518
    [Abstract] [Full Text] [Related]

  • 32. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292
    [Abstract] [Full Text] [Related]

  • 33. Corticosteroid therapy in IgA nephropathy with minimal proteinuria and high renal pathological score: A single‑center cohort study.
    Tang Y, He H, Sun W, Hu P, Chen X, Xu X.
    Mol Med Rep; 2018 Oct 03; 18(4):4103-4112. PubMed ID: 30132546
    [Abstract] [Full Text] [Related]

  • 34. Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy.
    Okabayashi Y, Tsuboi N, Haruhara K, Kanzaki G, Koike K, Shimizu A, Miyazaki Y, Ohno I, Kawamura T, Ogura M, Yokoo T.
    Clin Exp Nephrol; 2016 Dec 03; 20(6):910-917. PubMed ID: 26830548
    [Abstract] [Full Text] [Related]

  • 35. Immunosuppressive agents for treating IgA nephropathy.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Mar 12; 3(3):CD003965. PubMed ID: 32162319
    [Abstract] [Full Text] [Related]

  • 36. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS, Davlouros P, El Nahas AM, Ahuja M, Shortland JR, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2003 Mar 12; 93(2):C58-68. PubMed ID: 12616032
    [Abstract] [Full Text] [Related]

  • 37. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar 12; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 38. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy.
    Li Y, Xiong Y, Huang T, Liu X, Xu G.
    BMC Nephrol; 2021 Nov 04; 22(1):364. PubMed ID: 34736419
    [Abstract] [Full Text] [Related]

  • 40. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ, Bay RC, Jennette JC, Sibley R, Kumar S, Fervenza FC, Appel G, Cattran D, Fischer D, Hurley RM, Cerda J, Carter B, Jung B, Hernandez G, Gipson D, Wyatt RJ.
    Am J Kidney Dis; 2015 Nov 04; 66(5):783-91. PubMed ID: 26209543
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.